Pieter Droppert

Pieter Droppert is a management consultant, lawyer, science writer and editor of the Biotech Strategy Blog (http://biotechstrategyblog.com) on science, innovation and new product development in the pharma & biotech industries.

Recent posts

A Revolution is Taking Place in the Treatment of Blood Cancers
I try to avoid sensationalizing early clinical trial results presented at medical conferences, what’s commonly known as “hype over hope.” But at this year’s annual meeting of the American Society of... Read more »
Is Crowdfunding The Future For Biomedical Research?
Microryza.com (not the catchiest of names) is a crowdfunding platform for research that raises money over the Internet from individuals who are willing to donate small amounts to fund a specific... Read more »
Prostate Cancer Drug Winners and Losers at ASCO GU
The latest clinical research in prostate cancer is being presented at the American Society of Clinical Oncology Genitorinary Cancers Symposium (ASCO GU) in Orlando, FL. Presentations started yesterday, and run through... Read more »
Emerging Challenges of Prostate Cancer Drug Development
The world’s largest cancer meeting of scientists, physicians and industry has just ended in Chicago. The annual meeting of the American Society of Clinical Oncology (ASCO) attracted over 30,000 attendees to... Read more »
J&J Prostate Cancer Trial Shouldn’t Have Been Stopped Early
One of the more anticipated clinical trials at this year’s American Society of Clinical Oncology (ASCO) meeting was for Johnson & Johnson’s abiraterone (Zytiga) in prostate cancer patients. This study, known... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

From Our Editors · Podcast
Xcelerating Life Sciences Boston: The Highlights Podcast
Learn what's fueling Boston's biotech and digital health investment and partnership opportunities

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

New Xconomy Special Report: Biopharma and Tech Innovators Summer 2020

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

Roche Gets FDA OK for Injectable Version of Breast Cancer Drug

Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

Pieter Droppert

Recent posts

A Revolution is Taking Place in the Treatment of Blood Cancers

Is Crowdfunding The Future For Biomedical Research?

Prostate Cancer Drug Winners and Losers at ASCO GU

Emerging Challenges of Prostate Cancer Drug Development

J&J Prostate Cancer Trial Shouldn’t Have Been Stopped Early

Underwriters and Partners

Xcelerating Life Sciences Boston: The Highlights Podcast

Robert Langer reveals secrets to early-stage biotech success

How Big Is the US Market for Medical Devices & Technologies?

Xconomy on Demand

We offer a number of ways to subscribe for free!